Xeomin, a botulinum toxin therapy developed by Raleigh-based Merz Therapeutics, has gained yet another new use. The U.S. Food and Drug Administration approved Merz’s supplemental Biologics License ...
Raleigh-based Merz North America has received approval from the U.S. Food and Drug Administration to market a treatment for blepharospasm, or involuntary blinking, in adults. The treatment, Xeomin, is ...
Daxxify under Revance Therapeutics and Xeomin under Merz Aesthetics. Providers purchase these products directly from the company manufacturers to ensure that they are getting the real FDA-approved ...
This investment follows the strategic license and collaboration agreement signed in 2021 to utilize Merz’s botulinum neurotoxin A (XEOMIN ®) for the innovative ultrasound-assisted delivery ...
She looks amazing." While Aguilera, 43, has not commented on getting a facelift, she has been open about using Merz Aesthetics and Xeomin, an injectable that helps prevent frown lines. In March ...
etwa Xeomin, das bei neurologischen Bewegungsstörungen eingesetzt wird, und Bocouture, ein Produkt für die ästhetische Medizin. Durch die Erweiterung sollen am Standort über 50 neue Arbeitsplätze ...